• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Sanofi (ADR)

NYSE:SNY

$34.31 $0.08 (0.23%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 5

5/28/2012 by Seeking Alpha

Progenics Pharma: Several Short Term Catalysts With Good Long Term Fundamentals

5/25/2012 by Seeking Alpha

Abbott: Don't Miss Out On Its High Growth

5/25/2012 by Seeking Alpha

Mylan Launches Bonviva Generic - Analyst Blog

5/25/2012 by Nasdaq

Pfizer: Don't Overlook This $22 Gem

5/24/2012 by Seeking Alpha

Best of the Blogs, Biotech: Is an Anti-Obesity Drug Finally in Sight?

5/24/2012 by Minyanville

More Generic Launches for Mylan - Analyst Blog

5/24/2012 by Nasdaq

Healthcare Dogs Stay Steady In April

5/24/2012 by Seeking Alpha

JNJ Updates: Imodium Recalls; Heading For Chinese Acquisitions; Zytiga’s Success

5/23/2012 by Trefis

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr.

5/22/2012 by Nasdaq

Buffett and Woodford Agree on This One!

5/22/2012 by DailyFinance

Medivation Files Enzalutamide NDA - Analyst Blog

5/22/2012 by Nasdaq

Has Momenta Pharmaceuticals Become the Perfect Stock?

5/22/2012 by DailyFinance

Generic Launches Continue at Mylan - Analyst Blog

5/21/2012 by Nasdaq

Canada Approves Osiris' Prochymal - Analyst Blog

5/21/2012 by Nasdaq

Bristol-Myers Squibb's Thud Heard Round the World

5/20/2012 by DailyFinance

SPDR S&P 500 ETF and Bank of America Among Most Active Stocks in Pre-Market Today on the NYSE

5/17/2012 by Minyanville

FDA Approves Generic Versions Of Blood Thinning Drug Plavix

5/17/2012 by Smart Money

UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix

5/17/2012 by Smart Money

Manufacturing Facility Cleared at BMY - Analyst Blog

5/16/2012 by Nasdaq

Abbott Stands Up to Obamacare

5/16/2012 by DailyFinance

Lower than Expected Loss at Osiris - Analyst Blog

5/15/2012 by Nasdaq

Big Changes To Buffett & Berkshire Hathaway Stock Holdings, A to Z

5/15/2012 by 247wallst

Shorts Are Piling Into These Stocks. Should You Be Worried?

5/14/2012 by DailyFinance

Is This Biotech Upgrade Deserved?

5/14/2012 by DailyFinance

Sanofi Beats Analyst Estimates on EPS

5/11/2012 by DailyFinance

Sony’s Turnaround Dreams

5/10/2012 by 247wallst

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, B

5/10/2012 by 247wallst

Shutterfly’s Buying Growth And Rising Expenses Are A Concern

5/10/2012 by Trefis

Isis Loss Widens on Higher Expenses - Analyst Blog

5/9/2012 by Nasdaq

How Abbott Labs Can Gain at Pfizer’s Expense

5/9/2012 by Trefis

Can Dendreon's New Management Turn Things Around?

5/8/2012 by DailyFinance

PRESS RELEASE: Former Research Chemist At Global Pharmaceutical Company Sentenced To 18 Months In Pr

5/7/2012 by Smart Money

DOJ: Ex-Sanofi Chemist Sentenced To 18 Months For Trade Secrets Theft

5/7/2012 by Smart Money

Earnings Scorecard: Bristol-Myers - Analyst Blog

5/4/2012 by Nasdaq

Why Protalix BioTherapeutics Shares Soared

5/2/2012 by DailyFinance

This Biotech Needs to Strike Fast

5/2/2012 by DailyFinance

1 Biotech Back From the Dead

5/1/2012 by DailyFinance

CORRECT: FDA Approves Protalix, Pfizer Drug To Treat Gaucher Disease

5/1/2012 by Smart Money

UPDATE: FDA Approves Protalix, Pfizer Drug To Treat Gaucher Disease

5/1/2012 by Smart Money
See More Articles...